Schifano F, Curran H V
Clinical Psychopharmacology, Institute of Psychiatry, De Crespigny Park, London, UK.
Psychopharmacology (Berl). 1994 Jul;115(3):430-4. doi: 10.1007/BF02245086.
The effects of scopolamine (0.3, 0.6 mg IM) lorazepam (2 mg oral) and placebo on word valence ratings, priming and word recall were assessed in a double-blind independent group design with 36 subjects. Subjects given active drugs rated words as having more of an affective load than subjects given placebo. Priming, as assessed in a word-stem completion task, was not significantly affected by any treatment. Word recall showed some impairment following all active treatments. Performance on the stem completion task was unrelated to subjectively rated sedation but did not relate to word-valence ratings in different ways across drug treatments. Performance on the recall task was unrelated to valence ratings but did relate to the sedative effects on lorazepam. Implications are drawn out for pharmacological models of memory dysfunction.
采用双盲独立组设计,对36名受试者评估了东莨菪碱(0.3、0.6毫克,肌肉注射)、劳拉西泮(2毫克,口服)和安慰剂对单词效价评级、启动效应和单词回忆的影响。与服用安慰剂的受试者相比,服用活性药物的受试者对单词的情感负荷评级更高。在词干补全任务中评估的启动效应,未受到任何治疗的显著影响。所有活性治疗后,单词回忆均出现一定程度的损害。词干补全任务的表现与主观评定的镇静作用无关,但在不同药物治疗中与单词效价评级的关系方式不同。回忆任务的表现与效价评级无关,但与劳拉西泮的镇静作用有关。文中还探讨了对记忆功能障碍药理学模型的启示。